1 to 10 of 98 literature results

• Blood and marrow transplantation for sickle cell disease: overcoming barriers to success.

  PURPOSE OF REVIEW: Sickle cell disease (SCD) is a common health problem in the United States; yet, the only curative therapy, a bone marrow transplant…

  Authors: Javier Bolaños-Meade, Robert A Brodsky

  Source: Current opinion in oncology. 2009 Mar

  View Full Text

• Chronic graft-versus-host disease.

  Chronic graft-versus-host disease is the most common late, non-relapse complication of transplantation yet it is also one of the least studied. It is …

  Authors: Javier Bolaños-Meade, Georgia B Vogelsang

  Source: Current pharmaceutical design. 2008

  View Full Text

• Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: a randomized phase 2 trial from the Blood and Marrow Transplant Clinical Trials Network.

  Acute graft-versus-host disease (aGVHD) is the primary limitation of allogeneic hematopoietic cell transplantation. Corticosteroids remain the standar…

  Authors: Amin M Alousi, Daniel J Weisdorf, Brent R Logan, Javier Bolaños-Meade, Shelly Carter, Nancy Difronzo, Marcelo Pasquini, Steven C Goldstein, Vincent T Ho, Brandon Hayes-Lattin,…

  Source: Blood. 2009 Jul 16

  View Full Text

• Update on the management of acute graft-versus-host disease.

  PURPOSE OF REVIEW: Acute graft-versus-host disease is one of the commonest complications after allogeneic stem cell transplantation. Recent advances i…

  Authors: Javier Bolaños-Meade

  Source: Current opinion in oncology. 2006 Mar

  View Full Text

• Novel strategies for steroid-refractory acute graft-versus-host disease.

  PURPOSE OF REVIEW: Graft-versus-host disease is one of the commonest complications of allogeneic bone marrow or peripheral blood stem cell transplanta…

  Authors: Javier Bolaños-Meade, Georgia B Vogelsang

  Source: Current opinion in hematology. 2005 Jan

  View Full Text

• Reduced intensity HLA-haploidentical BMT with post transplantation cyclophosphamide in nonmalignant hematologic diseases.

  Allogeneic blood or marrow transplantation (BMT) is potentially curative for a variety of life-threatening nonmalignant hematologic diseases such as p…

  Authors: R A Brodsky, L Luznik, J Bolaños-Meade, M S Leffell, R J Jones, E J Fuchs

  Source: Bone marrow transplantation. 2008 Oct

  View Full Text

• Rapid complete response using intrathecal rituximab in a patient with leptomeningeal lymphomatosis due to mantle cell lymphoma.

  Mantle cell lymphoma (MCL) is a B-cell lymphoid tumor that expresses CD20 and is associated with a poor prognosis. Central nervous system involvement …

  Authors: Luis Villela, Mauricio García, Rocío Caballero, José R Borbolla-Escoboza, Javier Bolaños-Meade

  Source: Anti-cancer drugs. 2008 Oct

  View Full Text

• Preserving the chromatographic integrity of high-speed supercritical fluid chromatography separations using time-of-flight mass spectrometry.

  The advantage of high-speed time-of-flight-mass spectrometry (TOF-MS) detection for ultrafast qualitative supercritical fluid chromatography/mass spec…

  Authors: Ben J Bolaños, Manuel C Ventura, Michael J Greig

  Source: Journal of combinatorial chemistry. 2003 Jul-Aug

  View Full Text

• Effects of phosphoric acid on bovine enamel bleached with carbamide peroxide.

  The aim of this study was to measure the demineralization capacity of 37% phosphoric acid on bovine enamel at different time-points after bleaching wi…

  Authors: Carmen L S G de Medeiros, Santiago González-López, Maria V Bolaños-Carmona, Purificación Sanchez-Sanchez, Jorge Bolaños-Carmona

  Source: European journal of oral sciences. 2008 Feb

  View Full Text

• Salvage transplantation for allograft failure using fludarabine and alemtuzumab as conditioning regimen.

  Graft failure after allogeneic blood or marrow transplantation, although generally uncommon, can be a devastating complication. This report includes t…

  Authors: J Bolaños-Meade, L Luznik, M Muth, W H Matsui, C A Huff, B D Smith, M Y Levy, Y L Kasamon, L J Swinnen, J D Powell,…

  Source: Bone marrow transplantation. 2009 Mar

  View Full Text